La cadena de opciones muestra datos clave de las opciones de acciones de Allied Gaming a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Allied Gaming..

Allied Gaming (NASDAQ:AGAE) Bolsa, Cadena de Opciones

Allied Gaming

Allied Gaming & Entertainment Inc is an experiential entertainment company focused on providing a growing world of gamers with various experiences through renowned assets, products, and services.

News

CREV

Carbon Revolution Announces Nasdaq Non-Compliance Letter

<p>Rexford Industrial Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REXR#NYSE">REXR</a>) reported quarterly earnings of $0.59 per share which met the analyst consensus estimate. This is a 1.67 percent decrease over earnings of $0.60 per share from the same period last year.  The company reported quarterly sales of $241.568 million which missed the analyst consensus estimate of $248.801 million by 2.91 percent.  This is a 3.69 percent increase over sales of $232.973 million the same period last year.</p>


Earnings

Earnings Misses

REXR

Rexford Industrial Realty Q2 FFO $0.59, Inline, Sales $241.568M Miss $248.801M Estimate

<p>AAR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIR#NYSE">AIR</a>) reported quarterly earnings of $1.16 per share which beat the analyst consensus estimate of $1.01 by 14.85 percent. This is a 31.82 percent increase over earnings of $0.88 per share from the same period last year.  The company reported quarterly sales of $754.500 million which beat the analyst consensus estimate of $695.714 million by 8.45 percent.  This is a 14.93 percent increase over sales of $656.500 million the same period last year.</p>


Earnings Beats

AAR Q4 Adj. EPS $1.16 Beats $1.01 Estimate, Sales $754.500M Beat $695.714M Estimate

<p>Kinder Morgan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMI#NYSE">KMI</a>) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $0.27 by 2.56 percent. This is a 12 percent increase over earnings of $0.25 per share from the same period last year.  The company reported quarterly sales of $4.042 billion which beat the analyst consensus estimate of $3.748 billion by 7.86 percent.  This is a 13.16 percent increase over sales of $3.572 billion the same period last year.</p>


Kinder Morgan Q2 Adj. EPS $0.28 Beats $0.27 Estimate, Sales $4.042B Beat $3.748B Estimate

WIIM

SRPT

Sarepta Therapeutics shares are trading higher after the company announced it will engage in strategic restructuring and cost savings.

<p>This morning, I woke up to the sound of pounding rain on the roof of my bus and a generator that made me decide to take the day off. Add in some flash flooding, a Wi-Fi signal riding on Starlink, and it's already been a day to remember.</p>
<p>But even with all that going on, I had to get a story out to you because we've officially entered one of my favorite times of the year: earnings season.</p>
<p>This isn't just <em>any</em> earnings season, either. It's the second quarter (Q2) earnings, when the biggest batch of reports hits. But while most traders are busy guessing whether a stock will beat or miss expectations, we're going to take a different approach.</p>
<p>So today, I want to walk you through how I'm trading earnings this quarter, the patterns I'm spotting, and the stocks I've got on my radar right now.</p>
<h2 class="wp-block-heading"><em>FREE LIVE EVENT: "It's Like NVIDIA at $10 All Over Again"</em></h2>
<p><em>Tim Melvin is seeing the same setup that preceded NVIDIA's historic run. For the first time ever, he's partnering with trader Anne-Marie Baiynd to reveal where the next explosive opportunities are hiding. [Get Free Access <a href="https://events2.benzinga.com/next-10x-winner/?utm_campaign=072325-webinar&amp;el=ResearchDaily&amp;he={{email}}&amp;adt_ei={{email}}&amp;utm_adType=SponsorAd&amp;utm_ad=RD071725">HERE</a>]</em></p>
<h2 class="wp-block-heading">Why Most Traders Blow It on Earnings</h2>
<p>Let's get something out of the way: trading earnings <em>the day before</em> the announcement is a bad idea.</p>
<p>That's what I call "meme trading" or the "Robinhood crowd" mentality. You buy a call because you <em>hope</em> the stock will go up—or a put if you <em>think</em> it'll tank—and hold through earnings. That's a quick way to lose money, even if you're right on direction.</p>
<p>Why? Because of the volatility crush.</p>
<p>Implied volatility usually surges leading into earnings. But once the report drops? Volatility falls off a cliff—often faster than the stock price can move in your favor. That means even if you're "right," you can still lose money because the time premium gets obliterated.</p>
<p>So, what's the better play?  Trade the setup, <em>not</em> the outcome.</p>
<p>That means you want to <strong>get in one to two weeks before earnings</strong>, not the day before. And you want to <strong>get out before the report hits</strong>, selling to someone else who's willing to pay top dollar for all that pumped-up volatility.</p>
<p>I call it <em>"</em>scalping the implied volatility wave."</p>
<p>Now, if I can pair that volatility ramp with a strong directional pattern, that's where the real edge comes in. Some stocks tend to drift higher (or lower) into earnings like clockwork. And when price and volatility rise together, that's our signal to strike, which brings me to a few setups I've got my eye on.</p>
<h2 class="wp-block-heading">Pan American Silver</h2>
<p>I've been watching <strong>Pan American Silver </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAAS#NYSE">PAAS</a>) for a while. Over the last four quarters, PAAS has sold off in the week leading up to earnings, and each time, implied volatility has spiked. That's a textbook setup for put buyers.</p>
<p>Now, earnings aren't coming until August 6, but that gives us time to prepare. I'll be watching closely for the next dip and any IV surge. If we see both, I'll be looking to grab short-term options and ride them for a few days before the announcement.</p>
<h2 class="wp-block-heading">AbbVie</h2>
<p><strong>AbbVie </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) is the opposite of PAAS. This one has a bullish pattern leading up to earnings, with the stock moving higher ahead of the last few reports. Same deal—volatility ramps, price climbs, and that creates a sweet spot for call options.</p>
<p>Earnings drop on July 30, so again, we've got time. I'll be eyeing this one about 10 days out, especially if we see any early pullbacks that offer a cheaper entry.</p>
<h2 class="wp-block-heading">Why This Matters And What To Do Next</h2>
<p>A lot of traders think earnings are binary: either the stock beats expectations and pops, or it misses and crashes. But that's not how the smart money trades.</p>
<p>We're not gambling on outcomes, we're stacking probabilities.</p>
<p>We're looking for patterns that have played out multiple times, we're aligning with the natural volatility cycle, and we're getting out before the crowd even shows up.</p>
<p>Remember, I track the top 325 stocks every quarter to find these patterns. PAAS and ABBV are just two names with strong historical setups—but they're not the only ones. The more you study these moves, the easier it gets to spot consistent winners.</p>
<p>This week, I'll be running more scans and breaking down a few ETF setups as well (seasonality is back in play). And of course, I'll be keeping one eye on the headlines. After all, even a strong earnings setup can get shaken up by the 24/7 news cycle.</p>
<p>Until then, keep your watchlists tight, your entries clean, and your exits earlier than everyone else.</p>
<p><em>Editorial content from our expert contributors is intended to be information for the general public and not individualized investment advice. Editors/contributors are presenting their individual opinions and strategies, which are neither expressly nor impliedly approved or endorsed by Benzinga.</em></p>
<p><em>Photo: Shutterstock</em></p>


Opinion

Trading Ideas

ABBV

PAAS

My Top 2 Earnings Picks For This Earnings Season

<p><i><strong>Executive Leadership Appointments</strong></i><br /><br />In conjunction with the restructuring, Sarepta announced key executive appointments:</p>
<ul>
<li>Ian Estepan named President and Chief Operating Officer</li>
<li>Louise Rodino-Klapac, Ph.D., named President of Research &amp; Development and Technical Operations</li>
<li>Ryan Wong, named Chief Financial Officer, previously Senior Vice President of Strategic Finance, Treasury, and Investor Relations</li>
<li>Rachael Potter, Ph.D., named Chief Scientific Officer, previously Senior Vice President, Head of Research Sciences</li>
<li>Patrick Moss, Pharm.D., named Chief Commercial Officer, previously Senior Vice President of U.S. Market Access and Sales, succeeding Dallan Murray, Chief Customer Officer, who is leaving Sarepta. The Company thanks Mr. Murray for his long-time service and wishes him well.</li>
</ul>


Management

Sarepta Therapeutics Announces Ian Estepan Named President And Chief Operating Officer; Ryan Wong, Named Chief Financial Officer

Guidance

United Airlines Sees 6-Point Acceleration In Booking Demand In July; Expects Less Geopolitical, Macroeconomic Uncertainty In H2 2025

MMLP

Martin Midstream Partners Reaffirms FY Adj. EBITDA Guidance Of $109.1M

<p>– <i><strong>After strategic review, Sarepta focuses pipeline on high-impact programs, prioritizing potentially best-in-class siRNA platform assets</strong></i></p>
<p>– <i><strong>Strategic restructuring includes reduced operating expenses, delivering approximately $400 million in anticipated annual cost savings, and implementing a 36% workforce reduction of approximately 500 employees</strong></i></p>
<p>– <i><strong>Duchenne portfolio continues to deliver stable and robust revenues, with preliminary quarterly results showing total net product revenue of $513 million for the second quarter 2025</strong></i></p>
<p>– <i><strong>U.S. FDA has requested and Sarepta has agreed to include a black box warning in the ELEVIDYS label, resolving any material issues with the ambulant population indication</strong></i></p>
<p>– <i><strong>Sarepta has completed an Expert Committee on a protocol for the use of additional prophylactic immunosuppression for non-ambulant patients, and will submit the protocol to FDA imminently and discuss the pathway to resume shipment of ELEVIDYS for non-ambulant patients</strong></i></p>
<p>– <i><strong>Company to host investor call on July 16, 2025, at 4:30 p.m. Eastern time</strong></i></p>
<p>Sarepta Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>), the leader in precision genetic medicine for rare diseases, today announced a strategic restructuring plan designed to prioritize high-value, high impact programs, meet its 2027 financial obligations, and support its long-term financial viability. This plan is expected to position the Company for long-term sustainable growth, with an emphasis on near- and mid-term opportunities from the siRNA platform. These decisive changes aim to ensure sustained profitability and preserve the Company's ability to deliver on its mission of advancing innovative medicines for those with rare genetic diseases.</p>


Biotech

General

Sarepta Announces Strategic Restructuring With 36% Workforce Reduction And $400M In Annual Cost Savings, Refocuses Pipeline On siRNA Assets; Reports $513M In Q2 Revenue And Resolving FDA Issues For ELEVIDYS

<p>Martin Midstream Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMLP#NASDAQ">MMLP</a>) reported quarterly losses of $(0.06) per share. This is a 166.67 percent decrease over earnings of $0.09 per share from the same period last year.  The company reported $180.676 million in sales this quarter. This is a 2.09 percent decrease over sales of $184.531 million the same period last year.</p>


Martin Midstream Partners Q2 EPS $(0.06) Down From $0.09 YoY, Sales $180.676M Down From $184.531M YoY

MCRI

Monarch Casino & Resort Q2 EPS $1.44 Beats $1.22 Estimate, Sales $136.914M Beat $129.834M Estimate

<p>United Airlines Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>) lowers FY2025 Adj EPS guidance from $11.50-$13.50 to $9.00-$11.00 vs $10.05 analyst estimate..</p>


United Airlines Holdings Lowers FY2025 Adj EPS Guidance from $11.50-$13.50 to $9.00-$11.00 vs $10.05 Est

<p>Across the recent three months, 4 analysts have shared their insights on Monarch Casino &amp; Resort (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCRI#NASDAQ">MCRI</a>), expressing a variety of opinions spanning from bullish to bearish.</p>
<p>The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $94.5, a high estimate of $105.00, and a low estimate of $81.00. Observing a downward trend, the current average is 2.33% lower than the prior average price target of $96.75. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752696064_0.png" alt="price target chart" /></p>
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Monarch Casino &amp; Resort. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Barry Jonas</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$105.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Chad Beynon</td>
<td>Macquarie</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$92.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Jeffrey Stantial</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$81.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Barry Jonas</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$100.00</td>
<td>$105.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Monarch Casino &amp; Resort. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Monarch Casino &amp; Resort compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts gauge the dynamics of price targets, providing estimates for the future value of Monarch Casino &amp; Resort's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>To gain a panoramic view of Monarch Casino &amp; Resort's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/MCRI/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Monarch Casino &amp; Resort analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.</p>
<h2>Delving into Monarch Casino &amp; Resort's Background</h2>
<p>Monarch Casino &amp; Resort Inc is engaged in providing the latest gaming, dining, and hospitality amenities. It owns and operates the Atlantis Casino Resort Spa, a hotel/casino facility in Reno, Nevada, and the Monarch Black Hawk Casino in Black Hawk. The company generates the majority of its revenue from Casinos, followed by Food &amp; Beverage and Hotel Operations.</p>
<h3>Financial Insights: Monarch Casino &amp; Resort</h3>
<p><strong>Market Capitalization:</strong> Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.</p>
<p><strong>Revenue Growth:</strong> Monarch Casino &amp; Resort displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately <strong>3.07%</strong>. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> Monarch Casino &amp; Resort's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>15.84%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Monarch Casino &amp; Resort's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>3.77%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>2.83%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> Monarch Casino &amp; Resort's debt-to-equity ratio is below the industry average at <strong>0.03</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Analyst Ratings

A Glimpse Into The Expert Outlook On Monarch Casino & Resort Through 4 Analysts

<p>Financial giants have made a conspicuous bearish move on Cigna Group. Our analysis of options history for Cigna Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>) revealed 17 unusual trades.</p>
<p>Delving into the details, we found 23% of traders were bullish, while 64% showed bearish tendencies. Out of all the trades we spotted, 13 were puts, with a value of $765,142, and 4 were calls, valued at $432,675.</p>
<h3>Projected Price Targets</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $300.0 and $340.0 for Cigna Group, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Cigna Group's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Cigna Group's substantial trades, within a strike price spectrum from $300.0 to $340.0 over the preceding 30 days.</p>
<h3>Cigna Group Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752696057_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$51.8</td>
<td>$50.2</td>
<td>$50.2</td>
<td>$300.00</td>
<td>$336.3K</td>
<td>309</td>
<td align="right">70</td>
</tr>
<tr>
<td>CI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$13.9</td>
<td>$12.5</td>
<td>$12.5</td>
<td>$315.00</td>
<td>$108.7K</td>
<td>1.2K</td>
<td align="right">500</td>
</tr>
<tr>
<td>CI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$14.0</td>
<td>$12.9</td>
<td>$12.9</td>
<td>$315.00</td>
<td>$96.7K</td>
<td>1.2K</td>
<td align="right">581</td>
</tr>
<tr>
<td>CI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$12.8</td>
<td>$12.4</td>
<td>$12.8</td>
<td>$315.00</td>
<td>$64.4K</td>
<td>1.2K</td>
<td align="right">631</td>
</tr>
<tr>
<td>CI</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$12.7</td>
<td>$12.3</td>
<td>$12.7</td>
<td>$315.00</td>
<td>$54.6K</td>
<td>1.2K</td>
<td align="right">337</td>
</tr>
</tbody>
</table>
</p>
<h3>About Cigna Group</h3>
<p>Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.</p>
<p>After a thorough review of the options trading surrounding Cigna Group, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Cigna Group's Current Market Status</h3>
<ul>
<li>With a trading volume of 894,988, the price of CI is up by 1.04%, reaching $305.6.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 15 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Cigna Group</h3>
<p>1 market experts have recently issued ratings for this stock, with a consensus target price of $371.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Reflecting concerns, an analyst from RBC Capital lowers its rating to Outperform with a new price target of $371.</p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Cigna Group options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


Options

Markets

Cigna Group Options Trading: A Deep Dive into Market Sentiment

<p>4 analysts have expressed a variety of opinions on PennantPark Floating Rate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFLT#NYSE">PFLT</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.</p>
<p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $11.06, with a high estimate of $11.50 and a low estimate of $10.75. This current average has decreased by 5.87% from the previous average price target of $11.75. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752696055_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive PennantPark Floating Rate. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Vilas Abraham</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$10.75</td>
<td>$10.50</td>
</tr>
<tr>
<td>Matthew Condon</td>
<td>JMP Securities</td>
<td>Lowers</td>
<td>Market Outperform</td>
<td>$11.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Michael Diana</td>
<td>Maxim Group</td>
<td>Lowers</td>
<td>Buy</td>
<td>$11.50</td>
<td>$12.50</td>
</tr>
<tr>
<td>Mark Hughes</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$11.00</td>
<td>$12.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to PennantPark Floating Rate. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of PennantPark Floating Rate compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of PennantPark Floating Rate's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of PennantPark Floating Rate's market position. Stay informed and make well-informed decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/PFLT/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on PennantPark Floating Rate analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.</p>
<h2>All You Need to Know About PennantPark Floating Rate</h2>
<p>PennantPark Floating Rate Capital Ltd is a closed-end, externally managed, non-diversified investment company. Its investment objectives are to generate current income and capital appreciation by investing in Floating Rate Loans and other investments made to U.S. middle-market companies. The company believes that Floating Rate Loans to U.S. middle-market companies offer attractive risk-reward to investors due to the limited amount of capital available for such companies and the potential for rising interest rates. The company generate revenue in the form of interest income on the debt securities and dividends.</p>
<h3>Breaking Down PennantPark Floating Rate's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.</p>
<p><strong>Decline in Revenue:</strong> Over the 3M period, PennantPark Floating Rate faced challenges, resulting in a decline of approximately <strong>-90.1%</strong> in revenue growth as of 31 March, 2025. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.</p>
<p><strong>Net Margin:</strong> PennantPark Floating Rate's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>37.18%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> PennantPark Floating Rate's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>0.12%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> PennantPark Floating Rate's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of <strong>0.05%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>1.28</strong>.</p>
<h2>Understanding the Relevance of Analyst Ratings</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


PFLT

Analyst Expectations For PennantPark Floating Rate's Future

<p>Deep-pocketed investors have adopted a bearish approach towards Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in NKE usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 28 extraordinary options activities for Nike. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 35% leaning bullish and 46% bearish. Among these notable options, 8 are puts, totaling $1,070,292, and 20 are calls, amounting to $1,667,454.</p>
<h3>What's The Price Target?</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $50.0 to $95.0 for Nike over the last 3 months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Nike's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Nike's whale trades within a strike price range from $50.0 to $95.0 in the last 30 days. </p>
<h3>Nike Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752696052_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>NKE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$10.2</td>
<td>$10.05</td>
<td>$10.1</td>
<td>$75.00</td>
<td>$505.0K</td>
<td>606</td>
<td align="right">502</td>
</tr>
<tr>
<td>NKE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$8.05</td>
<td>$7.9</td>
<td>$8.05</td>
<td>$75.00</td>
<td>$362.2K</td>
<td>13.6K</td>
<td align="right">450</td>
</tr>
<tr>
<td>NKE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/17/27</td>
<td>$28.8</td>
<td>$27.9</td>
<td>$28.8</td>
<td>$50.00</td>
<td>$288.0K</td>
<td>775</td>
<td align="right">302</td>
</tr>
<tr>
<td>NKE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/17/27</td>
<td>$28.75</td>
<td>$28.7</td>
<td>$28.7</td>
<td>$50.00</td>
<td>$284.1K</td>
<td>775</td>
<td align="right">202</td>
</tr>
<tr>
<td>NKE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/17/27</td>
<td>$29.05</td>
<td>$28.75</td>
<td>$28.8</td>
<td>$50.00</td>
<td>$146.7K</td>
<td>775</td>
<td align="right">52</td>
</tr>
</tbody>
</table>
</p>
<h3>About Nike</h3>
<p>Nike is the largest athletic footwear and apparel brand in the world. Key categories include basketball, running, and football (soccer). Footwear generates about two thirds of its sales. Its brands include Nike, Jordan (premium athletic footwear and clothing), and Converse (casual footwear). Nike sells products worldwide through company-owned stores, franchised stores, and third-party retailers. The firm also operates e-commerce platforms in more than 40 countries. Nearly all its production is outsourced to contract manufacturers in more than 30 countries. Nike was founded in 1964 and is based in Beaverton, Oregon.</p>
<h3>Nike's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 6,679,254, the NKE's price is up by 0.01%, now at $72.0. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 76 days.</li>
</ul>
<h3>Expert Opinions on Nike</h3>
<p>Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $80.8.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; In a positive move, an analyst from Argus Research has upgraded their rating to Buy and adjusted the price target to $85.<br />
&#x2A; An analyst from Truist Securities persists with their Buy rating on Nike, maintaining a target price of $73.<br />
&#x2A; Consistent in their evaluation, an analyst from Truist Securities keeps a Buy rating on Nike with a target price of $85.<br />
&#x2A; An analyst from Deutsche Bank persists with their Buy rating on Nike, maintaining a target price of $71.<br />
&#x2A; Maintaining their stance, an analyst from Evercore ISI Group continues to hold a Outperform rating for Nike, targeting a price of $90. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Nike options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


Unpacking the Latest Options Trading Trends in Nike

<p>Banner (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BANR#NASDAQ">BANR</a>) reported quarterly earnings of $1.35 per share which beat the analyst consensus estimate of $1.31 by 3.29 percent. This is a 15.38 percent increase over earnings of $1.17 per share from the same period last year.  The company reported quarterly sales of $162.150 million which beat the analyst consensus estimate of $147.327 million by 10.06 percent.  This is a 8.28 percent increase over sales of $149.745 million the same period last year.</p>


BANR

Banner Q2 Adj. EPS $1.35 Beats $1.31 Estimate, Sales $162.150M Beat $147.327M Estimate

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>GE Vernova</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with GEV, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 72 uncommon options trades for GE Vernova.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 40% bullish and 20%, bearish.</p>
<p>Out of all of the special options we uncovered, 25 are puts, for a total amount of $3,063,605, and 47 are calls, for a total amount of $7,662,965.</p>
<h3>What's The Price Target?</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $150.0 to $750.0 for GE Vernova during the past quarter. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for GE Vernova's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of GE Vernova's whale activity within a strike price range from $150.0 to $750.0 in the last 30 days. </p>
<h3>GE Vernova Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752696046_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>GEV</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$16.5</td>
<td>$15.0</td>
<td>$15.2</td>
<td>$650.00</td>
<td>$4.2M</td>
<td align="right">30</td>
<td>2.8K</td>
</tr>
<tr>
<td>GEV</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$28.5</td>
<td>$25.6</td>
<td>$27.5</td>
<td>$450.00</td>
<td>$1.0M</td>
<td align="right">214</td>
<td>479</td>
</tr>
<tr>
<td>GEV</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/21/25</td>
<td>$28.7</td>
<td>$27.3</td>
<td>$27.7</td>
<td>$480.00</td>
<td>$554.0K</td>
<td align="right">201</td>
<td>237</td>
</tr>
<tr>
<td>GEV</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$44.8</td>
<td>$42.2</td>
<td>$42.95</td>
<td>$570.00</td>
<td>$214.7K</td>
<td align="right">247</td>
<td>367</td>
</tr>
<tr>
<td>GEV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>08/29/25</td>
<td>$168.5</td>
<td>$164.5</td>
<td>$166.4</td>
<td>$400.00</td>
<td>$182.9K</td>
<td align="right">1</td>
<td>12</td>
</tr>
</tbody>
</table>
</p>
<h3>About GE Vernova</h3>
<p>GE Vernova is a global leader in the electric power industry, with products and services that generate, transfer, convert, and store electricity. The company has three business segments: power, wind, and electrification. Power includes gas, nuclear, hydroelectric, and steam technologies, providing dispatchable power. The wind segment includes wind generation technologies, inclusive of onshore and offshore wind turbines and blades. Electrification includes grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, and storage of electricity from the point of generation to point of consumption.</p>
<p>Having examined the options trading patterns of GE Vernova, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Current Position of GE Vernova</h3>
<ul>
<li>With a trading volume of 1,535,023, the price of GEV is up by 0.07%, reaching $560.0.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 7 days from now.</li>
</ul>
<h3>What Analysts Are Saying About GE Vernova</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $605.4.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; In a cautious move, an analyst from GLJ Research downgraded its rating to Buy, setting a price target of $702.<br />
&#x2A; An analyst from Morgan Stanley persists with their Overweight rating on GE Vernova, maintaining a target price of $511.<br />
&#x2A; In a cautious move, an analyst from UBS downgraded its rating to Buy, setting a price target of $614.<br />
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for GE Vernova, targeting a price of $580.<br />
&#x2A; Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for GE Vernova, targeting a price of $620. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for GE Vernova with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


Market Whales and Their Recent Bets on GEV Options

<p>Coursera (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COUR#NYSE">COUR</a>) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.</p>
<p>Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets, analyzed by analysts, offer insights with an average target of $10.83, a high estimate of $12.00, and a low estimate of $9.00. This upward trend is apparent, with the current average reflecting a 4.84% increase from the previous average price target of $10.33.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1752696047_0.png" alt="price target chart" /></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<p>The analysis of recent analyst actions sheds light on the perception of Coursera by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Bryan Smilek</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$9.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Josh Baer</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$11.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Josh Baer</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$10.00</td>
<td>$9.00</td>
</tr>
<tr>
<td>Ryan MacDonald</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$11.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Sarang Vora</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$12.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Sarang Vora</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$12.00</td>
<td>$12.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Coursera. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Coursera compared to the broader market.</li>
<li><strong>Price Targets:</strong> Gaining insights, analysts provide estimates for the future value of Coursera's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Coursera's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/COUR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Coursera analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.</p>
<h2>Discovering Coursera: A Closer Look</h2>
<p>Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through three reporting segments: Consumer, Enterprise, and Degrees. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.</p>
<h3>Unraveling the Financial Story of Coursera</h3>
<p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Coursera's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of <strong>6.03%</strong>. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> Coursera's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>-4.35%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Coursera's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of <strong>-1.29%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Return on Assets (ROA):</strong> Coursera's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>-0.83%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> Coursera's debt-to-equity ratio is below the industry average at <strong>0.01</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.</p>
<p>Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


COUR

A Glimpse Into The Expert Outlook On Coursera Through 6 Analysts

Press Releases

AGAE to Co-Launch RythmX x Strawberry Music Festival in Macau's First 50,000-Capacity Outdoor Venue

Allied Gaming & Entertainment Receives Expected Nasdaq Notice Regarding Delayed Annual Report

Allied Gaming & Entertainment Receives Expected Nasdaq Notice Regarding Delayed Quarterly Report

Knighted Pastures Nominates Highly Qualified Director Candidates for Election to Allied Gaming's Board at Upcoming Annual Meeting

Allied Gaming & Entertainment Acknowledges Receipt of Notice from Dissident Shareholder

Allied Gaming & Entertainment Urges All Stockholders to Be Cautious About Misrepresented Assertions by Dissident Shareholder

Allied Gaming & Entertainment Files Lawsuit Against Knighted Pastures and Roy Choi et al. Alleging Violations of Federal Securities Laws

Allied Gaming & Entertainment Reports Nasdaq Communication Related to Procedural Delays

Allied Gaming & Entertainment Announces CEO Transition to Accelerate Strategic Growth and Innovation

Allied Invites All Stockholders to Join Forces in Shaping a Bright Future for the Company – An Open Letter to All Stockholders

ADEA

AGAE

Allied Gaming & Entertainment Inc. - Common Stock

Aureus Greenway Holdings Inc. - Common Stock

Aureus Greenway Holdings

Six Flags Entertainment Corporation Common Stock New

Six Flags Entertainment

Golden Heaven Group Holdings Ltd. - Class A Ordinary Shares

Golden Heaven Group Hldgs

Life Time Group Holdings, Inc. Common Stock

Life Time Group Hldgs

Lucky Strike Entertainment Corporation Class A Common Stock

Lucky Strike

Vail Resorts

Dave & Buster's Entertainment, Inc. - Common Stock

Dave & Buster's Enter

Planet Fitness

United Parks & Resorts

Pursuit Attractions and Hospitality, Inc. Common Stock

Pursuit Attractions

RCI Hospitality Holdings, Inc. - Common Stock

RCI Hospitality Hldgs

Xponential Fitness, Inc. Class A Common Stock

Comments

Allied Gaming

Allied Gaming (AGAE) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL